Evidence map›Paper›PMID 33387270›Full record

ArticleActa parasitologica2021

Investigation of Isolated Blastocystis Subtypes from Cancer Patients in Turkey.

Sefa Mülayim, Mehmet Aykur, Hande Dağcı, Semih Dalkılıç, Asude Aksoy, Mustafa Kaplan

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. An Update onMicroorganisms · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frequency and distribution ofParasite epidemiology and control · 2021
    Article
  9. The Coexistence ofBiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sefa MülayimDepartment of Medical Parasitology, Faculty of Medicine, Fırat University, 23119, Elazığ, Turkey. smulayim@firat.edu.tr.ORCID http://orcid.org/0000-0002-2671-5624
Mehmet AykurDepartment of Medical Parasitology, Faculty of Medicine, Ege University, 35100, İzmir, Turkey.ORCID http://orcid.org/0000-0002-6100-1037
Hande DağcıDepartment of Medical Parasitology, Faculty of Medicine, Ege University, 35100, İzmir, Turkey.ORCID http://orcid.org/0000-0003-1315-4247
Semih DalkılıçDepartment of Medical Parasitology, Faculty of Medicine, Fırat University, 23119, Elazığ, Turkey.ORCID http://orcid.org/0000-0002-6892-247X
Asude AksoyDepartment of Medical Oncology, Faculty of Medicine, Fırat University, 23119, Elazığ, Turkey.ORCID http://orcid.org/0000-0002-5609-9658
Mustafa KaplanDepartment of Medical Parasitology, Faculty of Medicine, Fırat University, 23119, Elazığ, Turkey.ORCID http://orcid.org/0000-0003-3413-312X
Fırat University · TREge University · TR

Funding

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 315S262
6 · The paper itself

Abstract

purposeIt is not clear that Blastocystis remains without damage to the digestive tract or has a pathogenic effect in relation to subtypes in immunocompromised people, such as cancer patients. The present study aimed to investigate the frequency and subtype distribution of Blastocystis in cancer patients who were followed-up and treated in the Oncology clinic of Firat University Hospital and to determine the clinical signs of infected sufferers.

methods201 patients aged ≥ 18 with a diagnosis of cancer were enrolled in this cross-sectional study. Patients' stool samples were examined between September 2017 and August 2019 by native-Lugol, trichrome staining. Microscopy-positive stool samples were subjected to DNA isolation and subtyped by Sequence Tagged Site (STS)-PCR analysis. The symptoms and demographic characteristics of the patients were also evaluated.

resultsTotally, 29 (14.4%) samples were positive for Blastocystis after all methods. 15 (51.7%) out of 29 samples were successfully subtyped by the sequenced-tagged site(STS)-PCR, while 14 (48.3%) could not be typed. Three subtypes of Blastocystis were detected: ST3 (40%), ST2 (33%), ST1 (20%), and one mixed infections with ST1/ST2 (6%). There was no statistically significant difference in terms of clinical findings and demographic characteristics.

conclusionThe outcomes of our study promote the idea that Blastocystis could be an asymptomatic and harmless commensal organism. However, more comprehensive molecular and clinical studies are needed to fully determine the pathogenicity and epidemiology of Blastocystis in cancer patients.

Indexed as

BlastocystisBlastocystis InfectionsNeoplasmsAgedCross-Sectional StudiesDNA, ProtozoanFecesGenetic VariationHumansPhylogenyTurkeyDNA, ProtozoanBlastocystisCancerImmunocompromisedSubtypeTurkey

Identifiers

PMID33387270
OpenAlexW3114881997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.